Background The optimal treatment of stage I non–small-cell lung carcinoma is subject to
debate. The aim of this study was to compare overall survival and oncologic outcomes of …

Background The recent emphasis on value‐based health care (VBHC) is thought to provide
new opportunities for shared decision‐making (SDM) in the Netherlands, especially when …

Abstract Stereotactic Body Radiotherapy (SBRT) represents a consolidated treatment option
for patients with medically inoperable early stage non-small cell lung cancer (NSCLC). The …

Background Stereotactic body radiotherapy (SBRT) has become the standard of care for
medically inoperable patients with peripherally located, early stage non-small cell lung …

We report quality of life and indirect costs from patient reported outcomes from the ROSEL
randomized control trial comparing stereotactic ablative radiotherapy (SABR, also known as …

Background Surgery and stereotactic ablative radiotherapy (SABR) are both curative
treatment options for patients with a stage I non-small cell lung cancer (NSCLC) …

Objectives Stage I non-small cell lung cancer (NSCLC) can be treated with either
Stereotactic Body Radiotherapy (SBRT) or Video Assisted Thoracic Surgery (VATS) …

Introduction Surgery is the preferred treatment for patients with early-stage non-small cell
lung cancer (NSCLC) while stereotactic body radiation therapy (SBRT) may be applied in …

Introduction There is an ongoing debate on the optimal treatment for stage I NSCLC, with
increasing evidence for comparable health outcomes after surgery and stereotactic body …

Objective The study objective was to evaluate trends in the use of surgical therapy for
patients with early-stage (IA-IIA) non–small cell lung cancer when stereotactic ablative …